OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19
Adrían V. Hernández, Yuani M. Roman, Vinay Pasupuleti, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 4, pp. 287-296
Closed Access | Times Cited: 220
Adrían V. Hernández, Yuani M. Roman, Vinay Pasupuleti, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 4, pp. 287-296
Closed Access | Times Cited: 220
Showing 26-50 of 220 citing articles:
Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists
A. Bosquet, C. Affo, L. Plaisance, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261843-e0261843
Open Access | Times Cited: 53
A. Bosquet, C. Affo, L. Plaisance, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261843-e0261843
Open Access | Times Cited: 53
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials
Ariel Izcovich, Reed Siemieniuk, Jessica Bartoszko, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e048502-e048502
Open Access | Times Cited: 46
Ariel Izcovich, Reed Siemieniuk, Jessica Bartoszko, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e048502-e048502
Open Access | Times Cited: 46
COVID-19: Diabetes Perspective—Pathophysiology and Management
Siva Dallavalasa, SubbaRao V. Tulimilli, Prakash Janhavi, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 184-184
Open Access | Times Cited: 23
Siva Dallavalasa, SubbaRao V. Tulimilli, Prakash Janhavi, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 184-184
Open Access | Times Cited: 23
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm
Alice S. Chau, Andrew G. Weber, Naomi I. Maria, et al.
Arthritis & Rheumatology (2020) Vol. 73, Iss. 1, pp. 23-35
Closed Access | Times Cited: 67
Alice S. Chau, Andrew G. Weber, Naomi I. Maria, et al.
Arthritis & Rheumatology (2020) Vol. 73, Iss. 1, pp. 23-35
Closed Access | Times Cited: 67
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform
Christopher T. Rentsch, Nicholas DeVito, Brian MacKenna, et al.
The Lancet Rheumatology (2020) Vol. 3, Iss. 1, pp. e19-e27
Open Access | Times Cited: 67
Christopher T. Rentsch, Nicholas DeVito, Brian MacKenna, et al.
The Lancet Rheumatology (2020) Vol. 3, Iss. 1, pp. e19-e27
Open Access | Times Cited: 67
Weekly updates of national living evidence-based guidelines: methods for the Australian living guidelines for care of people with COVID-19
Britta Tendal, Joshua P. Vogel, Steve McDonald, et al.
Journal of Clinical Epidemiology (2020) Vol. 131, pp. 11-21
Open Access | Times Cited: 65
Britta Tendal, Joshua P. Vogel, Steve McDonald, et al.
Journal of Clinical Epidemiology (2020) Vol. 131, pp. 11-21
Open Access | Times Cited: 65
Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis
Michael Putman, Yu Pei Eugenia Chock, Herman Tam, et al.
Arthritis & Rheumatology (2020) Vol. 73, Iss. 1, pp. 36-47
Open Access | Times Cited: 59
Michael Putman, Yu Pei Eugenia Chock, Herman Tam, et al.
Arthritis & Rheumatology (2020) Vol. 73, Iss. 1, pp. 36-47
Open Access | Times Cited: 59
Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis
Suvojit Hazra, Alok Ghosh Chaudhuri, Basant K. Tiwary, et al.
Life Sciences (2020) Vol. 257, pp. 118096-118096
Open Access | Times Cited: 58
Suvojit Hazra, Alok Ghosh Chaudhuri, Basant K. Tiwary, et al.
Life Sciences (2020) Vol. 257, pp. 118096-118096
Open Access | Times Cited: 58
The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review
Avi Kaye, Robert D. Siegel
PeerJ (2020) Vol. 8, pp. e10322-e10322
Open Access | Times Cited: 58
Avi Kaye, Robert D. Siegel
PeerJ (2020) Vol. 8, pp. e10322-e10322
Open Access | Times Cited: 58
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 56
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 56
A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma
Irbaz Bin Riaz, Huan He, Alexander J. Ryu, et al.
European Urology (2021) Vol. 80, Iss. 6, pp. 712-723
Closed Access | Times Cited: 53
Irbaz Bin Riaz, Huan He, Alexander J. Ryu, et al.
European Urology (2021) Vol. 80, Iss. 6, pp. 712-723
Closed Access | Times Cited: 53
Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action
Somayeh Sadeghi, Sara Soudi, Abbas Shafiee, et al.
Life Sciences (2020) Vol. 262, pp. 118493-118493
Open Access | Times Cited: 51
Somayeh Sadeghi, Sara Soudi, Abbas Shafiee, et al.
Life Sciences (2020) Vol. 262, pp. 118493-118493
Open Access | Times Cited: 51
Impact of COVID‐19 in Liver Disease Progression
Miguel Ángel Martı́nez, Sandra Franco
Hepatology Communications (2021) Vol. 5, Iss. 7, pp. 1138-1150
Open Access | Times Cited: 49
Miguel Ángel Martı́nez, Sandra Franco
Hepatology Communications (2021) Vol. 5, Iss. 7, pp. 1138-1150
Open Access | Times Cited: 49
Advancing lung organoids for COVID-19 research
Jelte van der Vaart, Mart M. Lamers, Bart L. Haagmans, et al.
Disease Models & Mechanisms (2021) Vol. 14, Iss. 6
Open Access | Times Cited: 46
Jelte van der Vaart, Mart M. Lamers, Bart L. Haagmans, et al.
Disease Models & Mechanisms (2021) Vol. 14, Iss. 6
Open Access | Times Cited: 46
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Paulo Ricardo Martins‐Filho, Lis Campos Ferreira, Luana Heimfarth, et al.
The Lancet Regional Health - Americas (2021) Vol. 2, pp. 100062-100062
Open Access | Times Cited: 45
Paulo Ricardo Martins‐Filho, Lis Campos Ferreira, Luana Heimfarth, et al.
The Lancet Regional Health - Americas (2021) Vol. 2, pp. 100062-100062
Open Access | Times Cited: 45
Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282688-e0282688
Open Access | Times Cited: 20
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282688-e0282688
Open Access | Times Cited: 20
Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19
Adrían V. Hernández, Yuani M. Roman, Vinay Pasupuleti, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 4, pp. 78-79
Open Access | Times Cited: 45
Adrían V. Hernández, Yuani M. Roman, Vinay Pasupuleti, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 4, pp. 78-79
Open Access | Times Cited: 45
Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners
Ioana Roxana Bordea, Edit Xhajanka, Sebastian Candrea, et al.
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1704-1704
Open Access | Times Cited: 44
Ioana Roxana Bordea, Edit Xhajanka, Sebastian Candrea, et al.
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1704-1704
Open Access | Times Cited: 44
Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain
Ángel Vila-Córcoles, Olga Ochoa‐Gondar, Eva M. Satué-Gracia, et al.
BMJ Open (2020) Vol. 10, Iss. 12, pp. e041577-e041577
Open Access | Times Cited: 43
Ángel Vila-Córcoles, Olga Ochoa‐Gondar, Eva M. Satué-Gracia, et al.
BMJ Open (2020) Vol. 10, Iss. 12, pp. e041577-e041577
Open Access | Times Cited: 43
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study
Chris A. Gentry, Mary Beth Humphrey, Sharanjeet K. Thind, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 11, pp. e689-e697
Open Access | Times Cited: 40
Chris A. Gentry, Mary Beth Humphrey, Sharanjeet K. Thind, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 11, pp. e689-e697
Open Access | Times Cited: 40
Review of registered clinical trials for the treatment of COVID‐19
Fatemeh Babaei, Mohammadreza Mirzababaei, Marjan Nassiri‐Asl, et al.
Drug Development Research (2020) Vol. 82, Iss. 4, pp. 474-493
Open Access | Times Cited: 40
Fatemeh Babaei, Mohammadreza Mirzababaei, Marjan Nassiri‐Asl, et al.
Drug Development Research (2020) Vol. 82, Iss. 4, pp. 474-493
Open Access | Times Cited: 40
The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review
Felix Scholkmann, Tanja Restin, Marco Ferrari, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 40
Felix Scholkmann, Tanja Restin, Marco Ferrari, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 40
Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper
Claire Iannizzi, Elena Dorando, Jacob Burns, et al.
Journal of Clinical Epidemiology (2021) Vol. 141, pp. 82-89
Open Access | Times Cited: 36
Claire Iannizzi, Elena Dorando, Jacob Burns, et al.
Journal of Clinical Epidemiology (2021) Vol. 141, pp. 82-89
Open Access | Times Cited: 36
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
Sarah Aherfi, Bruno Pradines, Christian Devaux, et al.
Future Microbiology (2021) Vol. 16, Iss. 17, pp. 1341-1370
Open Access | Times Cited: 34
Sarah Aherfi, Bruno Pradines, Christian Devaux, et al.
Future Microbiology (2021) Vol. 16, Iss. 17, pp. 1341-1370
Open Access | Times Cited: 34
Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
Donovan McGrowder, Fabian Miller, Melisa Anderson Cross, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 50-50
Open Access | Times Cited: 32
Donovan McGrowder, Fabian Miller, Melisa Anderson Cross, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 50-50
Open Access | Times Cited: 32
